Your browser doesn't support javascript.
loading
MetSCORE: a molecular metric to evaluate the risk of metabolic syndrome based on serum NMR metabolomics.
Gil-Redondo, Rubén; Conde, Ricardo; Bruzzone, Chiara; Seco, Maria Luisa; Bizkarguenaga, Maider; González-Valle, Beatriz; de Diego, Angela; Laín, Ana; Habisch, Hansjörg; Haudum, Christoph; Verheyen, Nicolas; Obermayer-Pietsch, Barbara; Margarita, Sara; Pelusi, Serena; Verde, Ignacio; Oliveira, Nádia; Sousa, Adriana; Zabala-Letona, Amaia; Santos-Martin, Aida; Loizaga-Iriarte, Ana; Unda-Urzaiz, Miguel; Kazenwadel, Jasmin; Berezhnoy, Georgy; Geisler, Tobias; Gawaz, Meinrad; Cannet, Claire; Schäfer, Hartmut; Diercks, Tammo; Trautwein, Christoph; Carracedo, Arkaitz; Madl, Tobias; Valenti, Luca; Spraul, Manfred; Lu, Shelly C; Embade, Nieves; Mato, José M; Millet, Oscar.
Afiliação
  • Gil-Redondo R; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, BRTA, CIBERehd, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.
  • Conde R; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, BRTA, CIBERehd, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.
  • Bruzzone C; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, BRTA, CIBERehd, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.
  • Seco ML; OSARTEN Kooperativa Elkartea, 20500, Arrasate-Mondragón, Spain.
  • Bizkarguenaga M; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, BRTA, CIBERehd, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.
  • González-Valle B; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, BRTA, CIBERehd, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.
  • de Diego A; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, BRTA, CIBERehd, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.
  • Laín A; Precision Medicine and Metabolism Laboratory, CIC bioGUNE, BRTA, CIBERehd, Bizkaia Technology Park, Bld. 800, 48160, Derio, Bizkaia, Spain.
  • Habisch H; Molecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria.
  • Haudum C; Department of Internal Medicine, Medical University, Graz, Austria.
  • Verheyen N; Department of Internal Medicine, Medical University and University Heart Center, Graz, Austria.
  • Obermayer-Pietsch B; Department of Internal Medicine, Medical University, Graz, Austria.
  • Margarita S; Precision Medicine Lab, Biological Resource Center and Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy.
  • Pelusi S; Precision Medicine Lab, Biological Resource Center and Transfusion Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milano, Milano, Italy.
  • Verde I; Health Sciences Research Centre (CICS-UBI), 6200-506, Covilhã, Portugal.
  • Oliveira N; Health Sciences Research Centre (CICS-UBI), 6200-506, Covilhã, Portugal.
  • Sousa A; Health Sciences Research Centre (CICS-UBI), 6200-506, Covilhã, Portugal.
  • Zabala-Letona A; CIC bioGUNE, BRTA, Derio, Bizkaia, Spain.
  • Santos-Martin A; CIBERONC, 28025, Madrid, Spain.
  • Loizaga-Iriarte A; Traslational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Unda-Urzaiz M; CIBERONC, 28025, Madrid, Spain.
  • Kazenwadel J; Traslational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Berezhnoy G; Department of Urology, Basurto University Hospital, 48013, Bilbao, Spain.
  • Geisler T; CIBERONC, 28025, Madrid, Spain.
  • Gawaz M; Traslational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Cannet C; Department of Urology, Basurto University Hospital, 48013, Bilbao, Spain.
  • Schäfer H; CIBERONC, 28025, Madrid, Spain.
  • Diercks T; Traslational Prostate Cancer Research Lab, CIC bioGUNE-Basurto, Biocruces Bizkaia Health Research Institute, Barakaldo, Spain.
  • Trautwein C; Department of Urology, Basurto University Hospital, 48013, Bilbao, Spain.
  • Carracedo A; Department for Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, University of Tübingen, 72076, Tübingen, Germany.
  • Madl T; Department for Preclinical Imaging and Radiopharmacy, Werner Siemens Imaging Center, University of Tübingen, 72076, Tübingen, Germany.
  • Valenti L; Department of Internal Medicine III, Cardiology and Angiology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Spraul M; Department of Internal Medicine III, Cardiology and Angiology, University Hospital Tübingen, 72076, Tübingen, Germany.
  • Lu SC; Bruker Biospin GmbH, Rudolf-Plank-Str. 23, 76275, Ettlingen, Germany.
  • Embade N; Bruker Biospin GmbH, Rudolf-Plank-Str. 23, 76275, Ettlingen, Germany.
  • Mato JM; NMR Platform, CIC bioGUNE, BRTA, Derio, Bizkaia, Spain.
  • Millet O; Department of Internal Medicine III, Cardiology and Angiology, University Hospital Tübingen, 72076, Tübingen, Germany.
Cardiovasc Diabetol ; 23(1): 272, 2024 Jul 24.
Article em En | MEDLINE | ID: mdl-39048982
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectroscopia de Ressonância Magnética / Biomarcadores / Valor Preditivo dos Testes / Síndrome Metabólica / Metabolômica Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Espectroscopia de Ressonância Magnética / Biomarcadores / Valor Preditivo dos Testes / Síndrome Metabólica / Metabolômica Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2024 Tipo de documento: Article